Two formulations of exemestane percutaneous, one for control of flavouring in cancer of the breast, skin,Pru00f3statas and other disturbances of flavouring and another of testosterone with or without exemestane for hormone replacement with or without control of flavouring

摘要

Two formulations of exemestane percutaneous, one for control of flavouring in cancer of the breast, skin,Pru00f3statas and other disturbances of flavouring and another of testosterone with or without exemestane for hormone replacement with or without control of flavouring.The invention is now presenting refers to two pharmaceutical formulations for transdermal drug administration net.It is characterized by comprising: (I) a quantity of clinically effective exemestane; (II) a clinically effective amount of testosterone; (III) propylene glycol as the sole solubilizing andOnly one excipient QSP.In preferred compositions of the invention concentrations, the function such as anti odorant of gradual release for the control of flavouring in patients with breast cancer, skin.Benign and malignant prostate hyperplasia and other problems caused by the disturbance of flavouring.When formulated with exemestane and testosterone exerts the function of male hormone replacement for release / gradual uptake of testosterone.Respecting the circadian cycle and controlling the flavouring of, through the gradual release and concomitant of exemestane, maintaining the balance between testosterone and estrogen.When formulated with only testosterone realization the function of hormone replacement without control of flavouring.